Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells

HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN- 

(2014) A. Mangalam et al.   JOURNAL OF IMMUNOLOGY

The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells

(2012) N. Sorvillo et al.   BLOOD

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

(2012) C. Jian et al.   BLOOD

Structural basis for self-recognition by autoimmune T-cell receptors

(2012) Yiyuan Yin et al.   IMMUNOLOGICAL REVIEWS

ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura

(2012) G. BETTONI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura

(2011) Marie-Luise John et al.   ANNALS OF HEMATOLOGY

Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection

(2011) Yiyuan Yin et al.   EMBO JOURNAL

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

(2011) W. Pos et al.   HAEMATOLOGICA

Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura

(2011) W. POS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

B and T lymphocytes in acquired Thrombotic Thrombocytopenic Purpura during disease remission

(2011) Mariagabriella Mariani et al.   THROMBOSIS RESEARCH

Amino acid residues Arg659, Arg660, and Tyr661 in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor

(2010) S.-Y. Jin et al.   BLOOD

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

(2010) X. L. Zheng et al.   HAEMATOLOGICA

HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians

(2010) P. COPPO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF

(2009) W. Pos et al.   BLOOD

Structural alterations in peptide–MHC recognition by self-reactive T cell receptors

(2009) Kai W Wucherpfennig et al.   CURRENT OPINION IN IMMUNOLOGY

ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor

(2009) Anthony N. Vomund et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

(2009) S. FERRARI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link

(2009) M. SCULLY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation

(2008) F. Banno et al.   BLOOD

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

(2008) J. E. Sadler   BLOOD

VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

(2008) W. POS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan

(2008) Morten Nielsen et al.   PLoS Computational Biology